China NMPA Product Recall - ENT Surgical Navigation System

Medtronic Navigation, Inc., in cooperation with Medtronic (Shanghai) Management Co., Ltd., has initiated a voluntary Class II recall of its Otolaryngology Surgical Navigation System. This recall, reported to the National Medical Products Administration (NMPA) on March 14, 2023, addresses a critical issue identified in the calibration process of specific models and batches of the device. The main concern stems from a problem with the device's calibration, which could potentially affect its accurate performance during surgical procedures. While the document does not detail specific inspection dates, the recall itself serves as a corrective action initiated by the manufacturer. Operating under the regulatory oversight of the NMPA, the company is undertaking this recall to ensure patient safety and product reliability. The required action for affected products is a voluntary recall, signifying the company's commitment to addressing the identified defect. Detailed information regarding the affected product models, specifications, and batches is available in the "Medical Device Announcement Form" and the "Medical Device Recall Event Report Form" provided by Medtronic (Shanghai) Management Co., Ltd. This proactive measure aims to mitigate any potential risks associated with the calibration issue, reinforcing the importance of stringent quality control in medical device manufacturing.